Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $21.0000 (0.96%) ($20.6200 - $21.5400) on Sat. Aug. 8, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 36 | Latest Price | $21.0000(0.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 1.4% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting TGTX price | TGTX will decline at least -2.015% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | 0 () | Intraday Trend | 1.6% | | | |
|
Resistance Level | $21.29 | 5 Day Moving Average | $20.75(1.2%) | 10 Day Moving Average | $20.46(2.64%) | 20 Day Moving Average | $21.29(-1.36%) | To recent high | -13% | To recent low | 25% | Market Cap | $N/A | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |